| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/08/2014 | CN103494806A Application and preparation method of benzo alpha-pyrone compounds |
| 01/08/2014 | CN103494795A Peptide compounds used for treating diseases associated with hyperexcitability disorders and dysfunction of an ion channel |
| 01/08/2014 | CN103494792A Compound phloroglucinol freeze-dried orally-disintegrating tablet and preparation method |
| 01/08/2014 | CN103494772A Compound phosphatide transfer body with high deformability and application thereof in preparing transdermal drug delivery preparation |
| 01/08/2014 | CN103494761A Pearl layer powder bath salt tablet and preparation method thereof |
| 01/08/2014 | CN103494741A Pure natural preservative for cosmetics |
| 01/08/2014 | CN103494201A Osteoarticular disease care product of L-ascorbyl dipalmitate |
| 01/08/2014 | CN103493923A Formula and production method of bitter gourd tea capable of reducing internal heat and reducing blood pressure |
| 01/08/2014 | CN103127415B Traditional Chinese medicine for treating post-stroke limb numbness |
| 01/08/2014 | CN103071117B Method for extracting curcuma oil and curcumine from rhizoma curcumae longae |
| 01/08/2014 | CN103070965B Chinese traditional medicine for relieving swelling and pain and promoting blood circulation to remove meridian obstruction |
| 01/08/2014 | CN102988665B Method for preparing gynecological menstruation regulating tablets and application |
| 01/08/2014 | CN102988576B Preparation method and application of nine-ingredient notopterygium root tablets |
| 01/08/2014 | CN102988502B Preparation method and application of Desheng tablet |
| 01/08/2014 | CN102940614B Method for preparing bulleyaconitine-containing tablets |
| 01/08/2014 | CN102846750B Fengtongning composite preparation and preparation method thereof |
| 01/08/2014 | CN102784355B First-aid drug and preparation method thereof |
| 01/08/2014 | CN102755597B Chinese medicine for treating acute soft tissue injury |
| 01/08/2014 | CN102727808B Drug for rapidly treating dysmenorrheal and abdomen mass |
| 01/08/2014 | CN102670734B Method for processing salted plantain seeds |
| 01/08/2014 | CN102670733B Preparation method for vinegar corydalis tuber |
| 01/08/2014 | CN102614330B Medicinal liquor for treating rheumatic arthritis |
| 01/08/2014 | CN102614230B Medicinal composition for treating rheumatoid arthritis and preparation method and application thereof |
| 01/08/2014 | CN102580142B Chinese medicinal liniment for postoperative healing of orthopaedic surgery and preparation method |
| 01/08/2014 | CN102432447B Cyclopentanone-containing curcumin monocarbonyl structural analogues and application thereof |
| 01/08/2014 | CN102427824B Prebiotic Composition |
| 01/08/2014 | CN102423424B Pathogenic fire dispelling and inflammation eliminating composition, preparation method, and pharmaceutical preparation thereof |
| 01/08/2014 | CN102078327B Application of hydrogen sulfide donor to preparation of medicine for treating central nervous system disease |
| 01/08/2014 | CN102015689B Inhibitors of JNK |
| 01/08/2014 | CN101903349B 4-(4-pyridinyl)-benzamides and application thereof as ROCK activity modulators |
| 01/08/2014 | CN101484467B Method for synthesizing thymosins |
| 01/08/2014 | CN101426772B Benzotriazine inhibitors of kinases |
| 01/07/2014 | US8623881 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 01/07/2014 | US8623839 Compositions and methods for stabilized polysaccharide formulations |
| 01/07/2014 | US8623833 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 01/07/2014 | US8623643 Antisense oligonucleotide modulation of STAT3 expression |
| 01/07/2014 | US8623431 Composition to enhance the bioavailability of curcumin |
| 01/07/2014 | US8623388 Denture care composition |
| 01/07/2014 | CA2712574C Polymorphic form of a [1,2,4]triazolo[4,3-a]pyridine derivative for treating inflammatory diseases |
| 01/07/2014 | CA2635813C Urea derivatives as kinase inhibitors and methods of use thereof |
| 01/07/2014 | CA2587248C Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies |
| 01/07/2014 | CA2542504C Lipids containing omega-3 and omega-6 fatty acids |
| 01/07/2014 | CA2461372C Dna sequences for human angiogenesis genes |
| 01/07/2014 | CA2453967C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/03/2014 | WO2014004902A2 Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof |
| 01/03/2014 | WO2014004417A1 Nicotinic receptor non-competitive antagonists |
| 01/03/2014 | WO2014004230A1 Dimethyl-benzoic acid compounds |
| 01/03/2014 | WO2014004229A1 Phenoxyethyl piperidine compounds |
| 01/03/2014 | WO2014003744A1 Anti-cxcl9, anti-cxcl 10, anti-cxcl 11, anti-cxcl 13, anti-cxcr3 and anti-cxcr5 agents for inflammatory disorder |
| 01/03/2014 | WO2014003742A1 Anti-cxcl9, anti-cxcl10, anti-cxcl11, anti-cxcl13, anti-cxcr3 and anti-cxcr5 agents for inhibition of inflammation |
| 01/03/2014 | WO2014003483A1 Fused pyrimidine derivatives having inhibitory activity on fms kinases |
| 01/03/2014 | WO2014002599A1 Crude-drug-containing pharmaceutical composition |
| 01/03/2014 | WO2014002042A1 Injectable supersaturated acetaminophen solution for spinal administration |
| 01/03/2014 | WO2014001802A1 2-aminopyrazine derivatives as csf-1 r kinase inhibitors |
| 01/03/2014 | WO2014001742A1 Advanced glycation end product analogues |
| 01/03/2014 | WO2014001464A1 Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and cns disorders |
| 01/03/2014 | WO2014001363A1 Novel tetrazole derivatives and their use as potassium channel modulators |
| 01/03/2014 | WO2014000452A1 Traditional chinese medicine compound gel for external treatment of cancer pain and preparation method for same |
| 01/03/2014 | WO2014000033A1 Polymer-nsaid conjugate |
| 01/03/2014 | WO2014000032A1 Phenyl amino pyrimidine bicyclic compounds and uses thereof |
| 01/03/2014 | WO2009158026A9 Hydrazonamide compounds that modulate hsp90 activity |
| 01/03/2014 | CA2877923A1 Phenyl amino pyrimidine bicyclic compounds and uses thereof |
| 01/03/2014 | CA2877589A1 Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and cns disorders |
| 01/03/2014 | CA2877449A1 2-aminopyrazine derivatives as csf-1 r kinase inhibitors |
| 01/03/2014 | CA2876801A1 Injectable supersaturated acetaminophen solution for spinal administration |
| 01/03/2014 | CA2876728A1 Polymer-nsaid conjugate |
| 01/03/2014 | CA2875572A1 Dimethyl-benzoic acid compounds |
| 01/03/2014 | CA2875569A1 Phenoxyethyl piperidine compounds |
| 01/02/2014 | US20140005272 Administration of n,n-dimethylacetamide and its monomethylated metabolites for the treatment of inflammatory disorders |
| 01/02/2014 | US20140005171 Ophthalmic Ointment Composition Comprising a Drug, an Ointment Base and a Solubilizing/Dispersing Agent |
| 01/02/2014 | US20140004603 Urocortin-iii and uses thereof |
| 01/02/2014 | US20140004095 Albumin fusion proteins |
| 01/01/2014 | EP2679595A2 Di-(3-deoxy-3-1H-1,2,3-triazol-1-yl)-[beta]-D-galacto-pyranosyl)sulfane |
| 01/01/2014 | EP2679230A1 Pharmaceutical formulation comprising compounds of the jasmonate family |
| 01/01/2014 | EP2678431A1 Oligonucleotide inhibitors with chimeric backbone and 2-amino-2'-deoxyadenosine |
| 01/01/2014 | EP2678342A1 N-substituted oxazinopteridines and oxazinopteridinones |
| 01/01/2014 | EP2678330A1 Crystalline forms and processes for the preparation of condensed azacycles ( cannabinoid receptor modulators) |
| 01/01/2014 | EP2678329A1 Triazolopyridine compounds as pim kinase inhibitors |
| 01/01/2014 | EP2678318A1 Cannabinoid receptor modulators |
| 01/01/2014 | CN103492389A Pyrazolo [4, 3-d] pyrimidines useful as kinase inhibitors |
| 01/01/2014 | CN103492377A Triazolopyridine compounds as PIM kinase inhibitors |
| 01/01/2014 | CN103492369A Cannabinoid receptor modulators |
| 01/01/2014 | CN103491968A Bee bloom compositions, methods of extraction and uses thereof |
| 01/01/2014 | CN103484339A Formula and production method of ginseng wine for invigorating blood circulation and removing blood stasis |
| 01/01/2014 | CN103484338A Formula and production method of pilose antler wine for invigorating blood circulation and removing blood stasis |
| 01/01/2014 | CN103484328A Indian buead and kudzuvine root wine and preparation method thereof |
| 01/01/2014 | CN103484318A Kidney-strengthening and tranquillizing liquor |
| 01/01/2014 | CN103484316A Hippocampus-pilose antler life-prolonging liquor |
| 01/01/2014 | CN103484313A Method for manufacturing wine by Chinese ivy fruits |
| 01/01/2014 | CN103483487A Novel structure product, preparation method and use of styrenic resin |
| 01/01/2014 | CN103483439A Alpha O-superfamily conotoxin peptide, and medicinal composition and use thereof |
| 01/01/2014 | CN103483226A Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto |
| 01/01/2014 | CN103483194A 2-fuloro fumarate (formula I), and preparation method and application thereof |
| 01/01/2014 | CN103483158A Diphenylethane derivatives and application thereof |
| 01/01/2014 | CN103480001A Acupoint massaging assisting preparation, preparation technology and application of preparation technology |
| 01/01/2014 | CN103479983A Ethnomedicine for treating rheumatic heart disease |
| 01/01/2014 | CN103479976A Prescription for treating common cold due to wind cold |
| 01/01/2014 | CN103479970A External medicine for treating rheumatic arthralgia |
| 01/01/2014 | CN103479967A Medicine composition for treating rheumatism |
| 01/01/2014 | CN103479963A Traditional Chinese medicine capsules for treating rheumatoid arthritis and preparation method thereof |